Summary
Introduction
Diazepam is widely used as an anxiolytic and hypnotic agent. However, there is an increased incidence of adverse effects (unwanted sedation, disorientation) amongst older people taking the drug (Boston Collaborative Drug Surveillance Programme, 1973) and it is unclear whether this enhanced sensitivity of the elderly is due to altered handling (a pharmacokinetic effect) or enhanced central nervous system sensitivity (a pharmacodynamic effect). The pharmacokinetics of diazepam in relation to age are complex:
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Subjects
Nineteen subjects (12 women) whose ages ranged from 18 to 95 years were studied. Four of these were normal volunteers, and the remainder were patients undergoing gastroscopy. Gastroscopic findings and results of conventional biochemical tests of liver function (serum bilirubin, serum aspartate transaminase, serum alkaline phosphatase) were normal in all cases. No subject gave a history of liver disease, or was taking drugs known to induce or inhibit hepatic microsoma1 oxidation. All abstained from alcohol for the duration of the study period. Subjects gave their informed consent, and the study had the approval of the Newcastle Area Health Authority (Teaching) and University Ethical Committees.
Experimental procedure
The subjects fasted overnight, and a venous blood sample was taken immediately before a single intravenous injection of diazepam (Valium, Roche). The dose in each subject was sufficient to achieve 'light anaesthesia' of a degree usually employed for gastroscopy, and varied between 5 and 30 mg (0.11-0.50 mg/kg). Venous blood samples were withdrawn at 24 h intervals for 7 days in all subjects. In eight subjects, additional venous blood samples were taken at 15 min intervals during the first 90 min after injection. Samples were obtained by repeated venepuncture, with a plastic syringe, and transferred to glass tubes containing lithium heparin, followed by immediate centrifugation and separation of plasma.
Analytical methods
Equilibrium dialysis of [ l4CIdiazepam [specific radioactivity 52.9 pCi (1.96 x lo6 Bq)/pmol)l was performed on plasma obtained after an overnight fast at a concentration of 1 pg/ml to determine the degree of protein binding in each individual. The [ ''C]diazepam was dissolved in 0.5 ml of isosmolar buffer (disodium hydrogen phosphate, 44.9 mmol/l; potassium dihydrogen phosphate, 11.2 mmol/l; sodium chloride, 87.7 mmol/l; pH 7-4) and dialysed against 0.5 ml of fresh plasma at 37OC for 8 h. Preliminary studies showed that equilibrium between plasma and buffer had been reached by this time. Two portions (200 pl) of buffer and plasma were placed in 10 ml of scintillation fluid [4 g of 2,5-diphenyloxazole and 0 -2 g of 1,4-bis-(5-phenyloxazol-2-yl)benzene dissolved in 667 ml of toluene and 333 ml of Triton-XI. To each vial 300 pl of water was added to achieve solubilization. Radioactivity was determined by liquid scintillation spectrometry and corrected for quenching by recounting the vials after the addition of 6.97 x pCi (258 Bq) of [14Cltoluene. The free fraction was calculated are the radioactivity of 114C]diazepam in buffer and plasma respectively. Each plasma sample was dialysed in duplicate and the mean coefficient of variation between then was 2.6%. In a pilot experiment we were unable to demonstrate any significant difference in the extent of protein binding between fasting and non-fasting plasma.
Total plasma concentrations of diazepam were measured, after double extraction, by gas-liquid chromatography with electron capture detection (de Silva & Puglisi, 1970) . Each estimation was (d.P.S.buTTer/(d.p.S.plasma); d*P*S*buwer and d.P*S' plasma performed in duplicate and the mean coefficient of variation between them was 6.4%. The lower limit of sensitivity at this level of accuracy was 5 ng/ml of plasma. There was clear chromatographic separation of diazepam from its major metabolite desmethyldiazepam. Serum albumin concentration was measured by the bromocresol green method (Doumas, Watson & Biggs, 197 1) .
Pharmacokinetic calculations
The plasma half-life (to.sp) of diazepam was calculated by least-squares regression analysis of the terminal monoexponential decay of plasma diazepam concentrations. The apparent volume of distribution (V,) was calculated from eqn. (l),
(1) where C, is the extrapolated plasma diazepam concentration at zero time. Total diazepam clearance (CltOt,,) was calculated (eqn. 2),
and free diazepam clearance (Clfree) from where f is the free (unbound) fraction of diazepam in plasma. 
Results
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concentrations in one subject after a single intravenous dose. In this individual, and in the other seven subjects in whom early sampling was undertaken, the plasma concentrations of diazepam (C,) were adequately described by a biexponential equation assuming a two-compartment open model: to increase log linearity with age (r = 0.863, P < 0.001) (Fig. 2) . The apparent distribution volume of free drug (mean 75.8 f SD 28.3 litres/kg) was correlated with age ( r = 0.648, P < 0-005) and clearance of the free fraction (mean 883 f SD 36 1 ml/min) declined significantly with increasing age (r= -0.717, P < 0.001) (Fig. 3) .
Serum albumin concentration (mean 39 f SD 6 g/l) declined with age (r = -0.863, P < 0.001) and was also correlated with the free fraction of diazepam (r = -0.830, P < 0.001).
Discussion
The pharmacokinetic variables calculated in the present study were derived from the terminal monoexponential decline in plasma diazepam concentrations and thus ignored the early exponential (eqn. 4) shown in Fig. 1 , and previously described by Klotz et al. (1975) . However, since the early exponential contributed less than 5% of the total area under the plasma concentration-time curve, we ignored this in order to reduce the number of blood samples in our patients and volunteers.
The protein binding of diazepam within individuals is reported to be constant over a wide range of concentrations in plasma (Van der Kleijn, van Rossum, Muskens & Rijntjes, 1971), which has since been confirmed (Peel, James, Macklon, Rawlins & Skillen, 1980) . This present study demonstrates wide interindividual differences in the degree of binding, which are to a large extent age-dependent. Klotz et al. (1975) did not demonstrate a relationship between age and protein binding, and it is possible that the use of radiolabelled drug by us has led to greater precision than can be achieved with gas-liquid chromatographic measurements of unlabelled diazepam at concentrations of less than 2 ng/ml. Since diazepam is predominantly bound in plasma to albumin (Peel et al., 1980) , the age-related changes in diazepam binding may be to a large extent related to the reduced serum albumin concentration seen in the elderly (Woodford-Williams, Alvarez, Webster, Landless & Dixon, 1964) , an observation confirmed amongst our subjects. However, not all of the variance in protein binding of diazepam can be attributed to serum albumin, and factors such as competition by endogenous ligands or qualitative differences in the albumin-binding sites may be involved. Total concentrations of diazepam in plasma do not accurately reflect the levels of free pharmacologically active drug. Reidenberg et al. (1978) observed that the total plasma diazepam concentration required to achieve light anaesthesia declined with age, and suggested that this was evidence for enhanced sensitivity of the elderly brain to the drug. When their data are corrected for the age-associated changes in binding which we report here, there is no significant correlation (r = -0.356, P > 0.05) between age and the free concentration apparently required to produce light anaesthesia.
The present investigation confirms the findings of Klotz et al. (1975) that the apparent total distribution volume of diazepam increases with age. Furthermore, we have now shown that the distribution volume of free drug also increases in the elderly. Since diazepam is very lipophilic, this may reflect the increase in the ratio of fat to lean body mass which occurs in ageing (Novak, 1972) .
Our observations that diazepam half-life increases with age, but that total diazepam clearance is not age-related, are similar to the findings of Klotz et al. (1975) . However, we have demonstrated that the clearance of free drug in plasma is decreased in the elderly. Diazepam undergoes extensive oxidative metabolism (Schwartz, Koechlin, Postma, Palmer & Krol, 1965) in man and the clearance of free drug, so-called 'intrinsic' clearance (Wilkinson & Shand, 1975) , is therefore a reflection of its rate of metabolism. Contrary, therefore, to the conclusions of previous workers, we conclude that diazepam metabolism is impaired in the elderly. Age-related changes in the oxidation of antipyrine (Stevenson, 1977) and acetanilide (Farah, Taylor, Rawlins & James, 1977) have been previously described but no satisfactory explanation has been advanced for these observations. Our studies therefore suggest that at least part of the increased sensitivity of the elderly to diazepam is due to pharmacokinetic factors. Smaller doses of the drug will be required to produce a defined degree of sedation after intravenous administration, and impaired metabolism will result in enhanced accumulation during chronic treatment. Further studies are required to elucidate the importance of pharmacodynamic factors to the sensitivity of elderly patients to this drug, by a grant from the Research Committee, Newcastle Area Health Authority (Teaching).
